This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Causative organisms

Authoring team

The microorganisms causing infective endocarditis include:

Infective agent and probability of being involved:

  • viridans Streptococci: - cause about 50% of episodes; mostly subacute infective endocarditis - Strep. sanguis, Strep. mitis, Strep. mutans, Strep milleri

  • enterococcal endocarditis - mainly with Enterococcus faecalis or Enterococcus faecium - about 10% of episodes - tends to occur in patients with lower gastrointestinal tract or genitourinary disease and may follow invasive procedure

  • Staphylococcus aureus - cause about 20% of episodes - Staph. aureus, Staph. epidermidis; in IV drug abusers S. aureus is commonest causing 50-60% of episodes

  • Fungi: 2-10% - Candida, Aspergillus, Histoplasma

In about 5% of patients with proven infective endocarditis, conventional blood cultures are negative. This may be due to infection with a difficult-to-culture or slow-growing organism e.g. gram-negative bacilli of the 'HACEK' group of oropharyngeal commensals, nutrionally variant streptococci and, rarely, Coxiella burnetti or Brucella species. Commonly culture-negativitity is a result of recent exposure to antimicrobial drugs.

Certain organisms are more common found in certain groups and these are illustrated in the linked pages below.

Reference:

Drugs and Therapeutics Bulletin (2002), 40 (4), 26-30.

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.